Literature DB >> 8100564

Genetic alterations in thyroid tumor progression: association with p53 gene mutations.

T Ito1, T Seyama, T Mizuno, N Tsuyama, Y Hayashi, K Dohi, N Nakamura, M Akiyama.   

Abstract

To identify the genetic events that must be involved in thyroid tumor progression, we initially investigated p53 gene alterations in 10 papillary adenocarcinomas, 4 follicular adenocarcinomas, and 8 undifferentiated carcinomas. Base substitutional mutations in exons 5 to 8 and loss of heterozygosity (LOH) of the p53 gene were not detected in papillary or follicular adenocarcinomas. However, 7 of 8 undifferentiated carcinomas were carrying base substitutional mutations, and LOH was detected in 3 of 5 informative cases. Furthermore, to verify that the p53 gene alterations are truly involved in tumor progression, DNA from individual foci of the four undifferentiated carcinomas coexisting with a differentiated focus and from one follicular adenocarcinoma with an undifferentiated focus was analyzed by direct sequencing and polymerase-chain-reaction-restriction-fragment-length polymorphism (PCR-RFLP). Base substitutional mutations in the p53 gene from exons 5 to 8 were identified exclusively in the undifferentiated foci, but not in the differentiated foci. LOH was observed in 3 of 4 informative undifferentiated foci. In one of these positive cases, LOH was observed in both papillary adenocarcinoma and undifferentiated carcinoma. However, a p53 gene mutation at codon 248 was detected in the undifferentiated carcinoma but not in the papillary adenocarcinoma. The results imply that LOH occurs first in papillary adenocarcinoma followed by a p53 mutation during the transition from papillary adenocarcinoma to undifferentiated carcinoma. Maintenance of LOH during tumor progression excludes the possibility that these different histological foci are derived from different origins and represents molecular evidence that undifferentiated carcinoma is very likely derived from preexisting papillary adenocarcinoma. Furthermore, these results strongly suggest that the mutated p53 gene plays a crucial role in de-differentiation during the progression of thyroid tumors.

Entities:  

Mesh:

Year:  1993        PMID: 8100564      PMCID: PMC5919182          DOI: 10.1111/j.1349-7006.1993.tb00171.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  24 in total

1.  Biallelic ApaI polymorphism of the human p53 gene (TP53).

Authors:  J Prosser; A Condie
Journal:  Nucleic Acids Res       Date:  1991-09-11       Impact factor: 16.971

2.  Pathology of thyroid tumors: some recent and old questions.

Authors:  J Rosai; M L Carcangiu
Journal:  Hum Pathol       Date:  1984-11       Impact factor: 3.466

3.  A new protocol and its rationale for the study of initiation and promotion of carcinogenesis in rat liver.

Authors:  V R Potter
Journal:  Carcinogenesis       Date:  1981       Impact factor: 4.944

4.  Anaplastic carcinoma of the thyroid. A clinicopathologic study of 121 cases.

Authors:  Y S Venkatesh; N G Ordonez; P N Schultz; R C Hickey; H Goepfert; N A Samaan
Journal:  Cancer       Date:  1990-07-15       Impact factor: 6.860

5.  Detection of retTPC/PTC transcripts in thyroid adenomas and adenomatous goiter by an RT-PCR method.

Authors:  Y Ishizaka; S Kobayashi; T Ushijima; S Hirohashi; T Sugimura; M Nagao
Journal:  Oncogene       Date:  1991-09       Impact factor: 9.867

Review 6.  The p53 tumour suppressor gene.

Authors:  A J Levine; J Momand; C A Finlay
Journal:  Nature       Date:  1991-06-06       Impact factor: 49.962

7.  Detection of the PTC/retTPC oncogene in human thyroid cancers.

Authors:  S M Jhiang; D R Caruso; E Gilmore; Y Ishizaka; T Tahira; M Nagao; I M Chiu; E L Mazzaferri
Journal:  Oncogene       Date:  1992-07       Impact factor: 9.867

8.  Mutational hotspot in the p53 gene in human hepatocellular carcinomas.

Authors:  I C Hsu; R A Metcalf; T Sun; J A Welsh; N J Wang; C C Harris
Journal:  Nature       Date:  1991-04-04       Impact factor: 49.962

9.  Identification of a chromosome 18q gene that is altered in colorectal cancers.

Authors:  E R Fearon; K R Cho; J M Nigro; S E Kern; J W Simons; J M Ruppert; S R Hamilton; A C Preisinger; G Thomas; K W Kinzler
Journal:  Science       Date:  1990-01-05       Impact factor: 47.728

10.  High frequency of ras oncogene activation in all stages of human thyroid tumorigenesis.

Authors:  N R Lemoine; E S Mayall; F S Wyllie; E D Williams; M Goyns; B Stringer; D Wynford-Thomas
Journal:  Oncogene       Date:  1989-02       Impact factor: 9.867

View more
  8 in total

1.  Previous External Beam Radiation Treatment Exposure Does Not Confer Worse Outcome for Patients with Differentiated Thyroid Cancer.

Authors:  Manish A Shaha; Laura Y Wang; Jocelyn C Migliacci; Frank L Palmer; Iain J Nixon; R Michael Tuttle; Ashok R Shaha; Jatin P Shah; Snehal G Patel; Ian Ganly
Journal:  Thyroid       Date:  2017-02-16       Impact factor: 6.568

2.  Insular and anaplastic carcinoma of the thyroid: a 45-year comparative study at a single institution and a review of the significance of p53 and p21.

Authors:  K Y Lam; C Y Lo; K W Chan; K Y Wan
Journal:  Ann Surg       Date:  2000-03       Impact factor: 12.969

Review 3.  Genetic alterations involved in the transition from well-differentiated to poorly differentiated and anaplastic thyroid carcinomas.

Authors:  Yuri E Nikiforov
Journal:  Endocr Pathol       Date:  2004       Impact factor: 3.943

Review 4.  P53 mutations in thyroid carcinoma: tidings from an old foe.

Authors:  N R Farid
Journal:  J Endocrinol Invest       Date:  2001 Jul-Aug       Impact factor: 4.256

5.  Recent advances in molecular diagnosis of thyroid cancer.

Authors:  Ioannis Legakis; Konstantinos Syrigos
Journal:  J Thyroid Res       Date:  2011-03-23

6.  Genetic alterations in poorly differentiated and undifferentiated thyroid carcinomas.

Authors:  Paula Soares; Jorge Lima; Ana Preto; Patricia Castro; João Vinagre; Ricardo Celestino; Joana P Couto; Hugo Prazeres; Catarina Eloy; Valdemar Máximo; M Sobrinho-Simões
Journal:  Curr Genomics       Date:  2011-12       Impact factor: 2.236

Review 7.  Recent developments in the investigation of thyroid regulation and thyroid carcinogenesis.

Authors:  G C Hard
Journal:  Environ Health Perspect       Date:  1998-08       Impact factor: 9.031

8.  bcl-2, p53 and proliferating cell nuclear antigen expression is related to the degree of differentiation in thyroid carcinomas.

Authors:  L Pollina; F Pacini; G Fontanini; S Vignati; G Bevilacqua; F Basolo
Journal:  Br J Cancer       Date:  1996-01       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.